These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25537772)
1. Modulation of Notch signaling as a therapeutic approach for liver cancer. Wu G; Wilson G; George J; Qiao L Curr Gene Ther; 2015; 15(2):171-81. PubMed ID: 25537772 [TBL] [Abstract][Full Text] [Related]
2. Is Notch Signaling a Specific Target in Hepatocellular Carcinoma? Sun L; Sun G; Yu Y; Coy DH Anticancer Agents Med Chem; 2015; 15(7):809-15. PubMed ID: 25642981 [TBL] [Abstract][Full Text] [Related]
3. Role of the Notch signaling in cholangiocarcinoma. Cigliano A; Wang J; Chen X; Calvisi DF Expert Opin Ther Targets; 2017 May; 21(5):471-483. PubMed ID: 28326864 [TBL] [Abstract][Full Text] [Related]
4. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
5. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI. Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108 [TBL] [Abstract][Full Text] [Related]
6. Targeting cancer stem cells as a therapeutic approach in liver cancer. Zhou G; Wilson G; George J; Qiao L Curr Gene Ther; 2015; 15(2):161-70. PubMed ID: 25537770 [TBL] [Abstract][Full Text] [Related]
7. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis. Xue TC; Zhang BH; Ye SL; Ren ZG Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma. Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164 [TBL] [Abstract][Full Text] [Related]
9. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway. Ma L; Dong P; Liu L; Gao Q; Duan M; Zhang S; Chen S; Xue R; Wang X Biochem Biophys Res Commun; 2016 Apr; 473(2):503-10. PubMed ID: 27003260 [TBL] [Abstract][Full Text] [Related]
11. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation. Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389 [TBL] [Abstract][Full Text] [Related]
12. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Giovannini C; Fornari F; Piscaglia F; Gramantieri L Cells; 2021 Mar; 10(3):. PubMed ID: 33804511 [TBL] [Abstract][Full Text] [Related]
13. The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma. Gil-García B; Baladrón V Biol Cell; 2016 Feb; 108(2):29-40. PubMed ID: 26621221 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic role of the Notch pathway in primary liver cancer. Lu J; Xia Y; Chen K; Zheng Y; Wang J; Lu W; Yin Q; Wang F; Zhou Y; Guo C Oncol Lett; 2016 Jul; 12(1):3-10. PubMed ID: 27347091 [TBL] [Abstract][Full Text] [Related]
16. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma. Gailhouste L; Ochiya T Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781 [TBL] [Abstract][Full Text] [Related]
17. Notch-associated microRNAs in cancer. Mo YY; Tang H; Miele L Curr Drug Targets; 2013 Sep; 14(10):1157-66. PubMed ID: 23834150 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of Notch signaling with special emphasis on microRNAs: Implications for glioma. Yan D; Hao C; Xiao-Feng L; Yu-Chen L; Yu-Bin F; Lei Z J Cell Physiol; 2018 Jan; 234(1):158-170. PubMed ID: 30076599 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Roles of the Notch Signaling Pathway in Liver Repair and Regeneration: A Novel Therapeutic Target. Valizadeh A; Sayadmanesh A; Asemi Z; Alemi F; Mahmoodpoor A; Yousefi B Curr Med Chem; 2021; 28(41):8608-8626. PubMed ID: 33874861 [TBL] [Abstract][Full Text] [Related]
20. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]